- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | NEXGEL GAAP EPS of -$0.11 misses by $0.01, revenue of $2.94M beats by $0.09M | 2 | Seeking Alpha | ||
| 13.11. | NEXGEL, INC.: NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially | 30 | GlobeNewswire (Europe) | Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing Gross profit margin for the quarter was 43.6% compared to 28.2% in... ► Artikel lesen | |
| 13.11. | NEXGEL, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.11. | A Peek at NexGel's Future Earnings | 3 | Benzinga.com | ||
| 11.11. | NEXGEL announces $2M registered direct offering | 5 | Seeking Alpha | ||
| 11.11. | NEXGEL, INC.: NEXGEL Announces $2,000,000 Registered Direct Offering | 2 | GlobeNewswire (USA) | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| 11.11. | NEXGEL, INC.: NEXGEL to Report Third Quarter 2024 Financial Results on November 13th | 1 | GlobeNewswire (USA) | ||
| 08.11. | Nexgel-Aktie erreicht 52-Wochen-Hoch bei 3,25 US-Dollar | 8 | Investing.com Deutsch | ||
| 08.11. | Nexgel stock soars to 52-week high, hits $3.25 | 1 | Investing.com | ||
| 28.10. | NEXGEL, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.10. | NEXGEL reports 133% increase in prelim revenue for Q3 | 4 | Seeking Alpha | ||
| 10.10. | NEXGEL, INC. - 8-K, Current Report | - | SEC Filings | ||
| 10.10. | NEXGEL, INC.: NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially | 90 | GlobeNewswire (Europe) | LANGHORNE, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle... ► Artikel lesen | |
| 04.10. | NEXGEL, INC.: NEXGEL Appoints Kip Crecca to its Scientific Advisory Board | 2 | GlobeNewswire (USA) | ||
| 28.08. | Nexgel director Stein buys $25,000 in company stock | 2 | Investing.com | ||
| 28.08. | Nexgel director Henry Scott Robert buys $25,000 in company stock | 1 | Investing.com | ||
| 28.08. | Nexgel director Jerome Zeldis buys $25,000 in company stock | 1 | Investing.com | ||
| 28.08. | Nexgel CFO Adam Drapczuk acquires $25,000 in company stock | 1 | Investing.com | ||
| 28.08. | NexGel director Steven Glassman buys $25,000 in company stock | 1 | Investing.com | ||
| 19.08. | NEXGEL, INC. - 10-Q, Quarterly Report | 2 | SEC Filings |
Seite:
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 71,86 | +0,66 % | Aktienmarkt: Starke Nachfrage treibt Kurs der Aktie von Dexcom (71,3101 €) | Im US-amerikanischen Wertpapierhandel brilliert zur Stunde der Anteilsschein von Dexcom . Das Wertpapier verteuert sich heute deutlich. Zu den auffälligsten Werten am US-amerikanischen Aktienmarkt gehört... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| ELEKTA | 5,365 | -0,09 % | Dividendenbekanntmachungen (06.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,08 USD 0,072 EUR ACUSHNET HOLDINGS CORP US0050981085 0,215 USD 0,1935 EUR ADMIRAL GROUP PLC ADR US0071921078 0... ► Artikel lesen | |
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| IMUNON | 0,635 | -2,31 % | Imunon, Inc.: IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting | IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| ALPHATEC | 9,200 | 0,00 % | Alphatec files to sell 1.13M shares of common stocks by selling shareholders | ||
| INTELLIGENT BIO SOLUTIONS | 1,475 | 0,00 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest |
NEXGEL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,305 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXGEL INC finden Sie auf Wallstreet Online.
